AsaharaT., MuroharaT., SullivanA.et al.1997. Isolation of putative progenitor endothelial cells for angiogenesis. Science, 275:964.
2.
Investigators of the Cardiovascular Cell Therapy Research Network (CCTRN). 2013. In Memoriam: Sonia I. Skarlatos (1953–2013)Circ. Res., 113:1034.
3.
MarchK.L.1997. Gene Transfer in the Cardiovascular System: Experimental Approaches and Therapeutic Implications. Kluwer Academic Publishers: Boston.
4.
MarchK.L., MadisonJ.E., TrapnellB.C.1995. Pharmacokinetics of adenoviral vector-mediated gene delivery to vascular smooth muscle cells: modulation by poloxamer 407 and implications for cardiovascular gene therapy. Hum. Gene Ther., 6:41–53.
5.
McDonaldC.2013. Dr. Sonia Skarlatos and NHLBI Translational Research and Resource Programs. Hum. Gene Ther., 24:899–905.
6.
MitterederN., MarchK.L., TrapnellB.C.1996. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J. Virol., 70:7498–7509.
7.
SimariR., MoyéL., SkarlatosS.et al.2009. Development of a network to test strategies in a cardiovascular cell delivery: The NHLB1-Sponsored Cardiovascular Cell Therapy Research Network (CCTRN)J. Cardiovasc. Transl. Res., 23:30–36.
